Drug firm Alembic Pharmaceuticals on Wednesday said it has received approval from the US health regulator for Vardenafil Hydrochloride tablets, indicated for the treatment of erectile dysfunction.The approved product is therapeutically equivalent to the reference listed drug product Levitra tablets of Bayer Healthcare Pharmaceuticals Inc.The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA)Vardenafil Hydrochloride tablets in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg, Alembic Pharmaceuticals said in a BSE filing.Close Quoting IQVIA data, the company said, Vardenafil Hydrochloride tablets have an estimated market size of $35 million for twelve months ending June 2020.Alembic now has a total of 127 ANDA approvals (112 final approvals and 15 tentative approvals) from USFDA.Shares of Alembic Pharmaceuticals were trading 0.31 percent higher at Rs 1,020.30 apiece on the BSE.
- NHS to get revolutionary new ovarian cancer drug
- Concussion linked to erectile dysfunction in ex-US football pros
- Will George Long or Matt Ingram get the nod to be number one?
- Nicholls hopes to get the nod against Liverpool
- Patchell gets the nod to start against Irish
- ICYMI: Charity leader gets royal nod
- McConnochie gets the nod for England
- MPs to debate cystic fibrosis drug Orkambi in Parliament
- Patient care being hit by drug shortages, pharmacist warns
- Drug lords will run our government, warns Tonga’s psychiatrist
Alembic Pharmaceuticals gets USFDA nod for erectile dysfunction drug have 226 words, post on www.moneycontrol.com at August 5, 2020. This is cached page on Business Breaking News. If you want remove this page, please contact us.